During the corresponding time, Stereotaxis Inc saw a revenue deteriorated by -10.6 % year on year, sequentially revenue grew by 32.38 %. While revenue at the Stereotaxis Inc 's corporate clients
Stereotaxis Inc., a leading player in the field of surgical robotics, has recently made significant strides in advancing its cardiac care technology. The company announced the achievement of a CE mark in Europe and the submission of a 510(k) application to the U.S. Food and Drug Administration (FDA) for its innovative semi-mobile robotic system, GenesisX. This regulatory progress highlights the company’s commitment to developing cutting-edge solutions for minimally invasive endovascular procedures.The GenesisX system is designed to enhance precision and accessibility in cardiac interventions, aimed at improving patient outcomes. With the CE mark already secured, Stereotaxis can begin marketing the GenesisX...
In a groundbreaking development, the Hospital Santa Maria della Pietà, located in Nola in the Metropolitan City of Naples, has launched Southern Italy s first-ever robotic cardiac heart program. This state-of-the-art technology marks a significant milestone in the region s medical history, promising advanced and precise treatment options for heart rhythm patients.Robotic Cardiac Heart Program:The introduction of the robotic cardiac heart program at Santa Maria della Pietà is set to revolutionize the way cardiac patients receive treatment in Southern Italy. This cutting-edge technology uses a sophisticated robotic-assisted system to perform intricate cardiac procedures, delivering exceptional precision, eff...
Intermountain Health Pioneers Revolutionary Robotic Technology in Heart Care AdvancementsIntermountain Medical Center, located in the heart of Utah, is set to revolutionize the field of cardiovascular care with the adoption of advanced robotic technology. This landmark makes Intermountain the first hospital in both the region and the state to embrace this cutting-edge innovation in heart care.The new technology represents a significant stride forward, showcasing Intermountain s commitment to providing patients with the best possible care. The integration of robotics promises to enhance precision, efficiency, and overall outcomes in cardiac procedures, solidifying the hospital s position as a leader in innova...
Sources:
Stereotaxis Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Stereotaxis Inc’s corporate clients.
For your research, we’ve provided 9 tables on Stereotaxis Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
36.48 %